BioLineRx BLRX
NASDAQ BLRX
$2.36 -0.07 (-2.88%)
As of: Sep 29, 2026 · 3:07 PM EDT

BioLineRx (BLRX) Total Liabilities (2010 - 2026)

Updated

BioLineRx's Total Liabilities was $16.86 million in the quarter ended Jun 30, 2026, down 27.3% from $23.2 million a year earlier and down 6.1% from the prior quarter.

Analysis

BioLineRx (BLRX) Total Liabilities (2010 - 2026) Analysis & Trends

As of Dec 31, 2025, Total Liabilities at BioLineRx came in at $17.56 million, down 31.0% from the prior year.

  • Total Liabilities shows a five-year compound annual growth rate of -7.0% (years ended Dec 2020 to Dec 2025).
  • In earlier years, Total Liabilities was $25.45 million in the year ended Dec 31, 2024 (-49.8%), $50.7 million in the year ended Dec 31, 2023 (+98.5%), $25.54 million in the year ended Dec 31, 2022 (+92.0%) and $13.3 million in the year ended Dec 31, 2021 (-47.3%).
  • The figure for the quarter ended Jun 30, 2026 marks the lowest quarterly Total Liabilities since the quarter ended Jun 30, 2022.
  • Compared with a year earlier, Total Liabilities has declined for seven straight quarters, with an average decline of 33.4% over the last eight quarters.
  • The best year-over-year quarter for Total Liabilities over five years was the quarter ended Jun 30, 2023 (growth of 236.1%); the worst was the quarter ended Sep 30, 2025 (a decline of 54.2%).
  • Per Business Quant data, BLRX's Total Liabilities in the three quarters before the quarter ended Jun 30, 2026 was $17.96 million (quarter ended Mar 31, 2026), $17.56 million (quarter ended Dec 31, 2025) and $20.27 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 116.09 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 141.05 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 87.82 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 80.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 65.46 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 83.95 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 37.53 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 115.64 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 7.18 Bn
10 BioLineRx 6.34 Bn 6.35 Bn 235,000.00 16.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 16.86 Mn
Mar 31, 2026 17.96 Mn
Dec 31, 2025 17.56 Mn
Sep 30, 2025 20.27 Mn
Jun 30, 2025 23.20 Mn
Mar 31, 2025 22.65 Mn
Dec 31, 2024 25.45 Mn
Sep 30, 2024 44.24 Mn
Jun 30, 2024 50.62 Mn
Mar 31, 2024 38.54 Mn
Dec 31, 2023 50.70 Mn
Sep 30, 2023 39.72 Mn
Jun 30, 2023 37.88 Mn
Mar 31, 2023 29.53 Mn
Dec 31, 2022 25.54 Mn
Sep 30, 2022 26.15 Mn
Jun 30, 2022 11.27 Mn
Mar 31, 2022 11.36 Mn
Dec 31, 2021 13.30 Mn
Sep 30, 2021 16.00 Mn
API Access

BioLineRx Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=BLRX&period=max&api_key=YOUR_API_KEY